An investigational prescription digital therapeutic (PDT) designed to treat negative [...]

Boston-based Strand Therapeutics has raised $153 million in a Series [...]

Cleanroom microbiology solutions specialist Cherwell is set to be renamed [...]

Citi Pharma has partnered with Xin Weisheng to build an [...]

The Court of Justice of the European Union (CJEU) has [...]

Advarra, known for regulatory reviews and clinical research technology, has [...]

ScaleReady has awarded a $100,000 G-Rex grant to Sidra Medicine, [...]

A genetically targeted approach to depression treatment has shown promising [...]

Revolo Biotherapeutics says it is accelerating plans to bring a [...]

James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.